EUR 6.1
(1.67%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 106.01 Million EUR | 5.79% |
2022 | 100.2 Million EUR | 14.44% |
2021 | 87.55 Million EUR | 5.86% |
2020 | 82.71 Million EUR | -6.31% |
2019 | 88.28 Million EUR | -13.92% |
2018 | 102.55 Million EUR | 2.22% |
2017 | 100.33 Million EUR | 7.48% |
2016 | 93.35 Million EUR | 15.56% |
2015 | 80.78 Million EUR | 13.64% |
2014 | 71.09 Million EUR | 22.09% |
2013 | 58.22 Million EUR | 15.84% |
2012 | 50.26 Million EUR | 6.39% |
2011 | 47.24 Million EUR | 0.0% |
2010 | - EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q4 | 56.94 Million EUR | 0.0% |
2023 Q2 | 49.05 Million EUR | 0.0% |
2022 Q2 | 45.2 Million EUR | 0.0% |
2022 FY | 100.2 Million EUR | 14.44% |
2022 Q4 | 54.99 Million EUR | 0.0% |
2021 Q2 | 48.09 Million EUR | 0.0% |
2021 FY | 87.55 Million EUR | 5.86% |
2021 Q4 | 39.46 Million EUR | 0.0% |
2020 Q2 | 45.9 Million EUR | 0.0% |
2020 Q4 | 49.59 Million EUR | 0.0% |
2020 FY | 82.71 Million EUR | -6.31% |
2019 FY | 88.28 Million EUR | -13.92% |
2019 Q2 | 49.83 Million EUR | 0.0% |
2019 Q4 | 38.45 Million EUR | 0.0% |
2018 Q4 | 55.45 Million EUR | 0.0% |
2018 FY | 102.55 Million EUR | 2.22% |
2018 Q2 | 47.1 Million EUR | 0.0% |
2017 Q4 | 55.67 Million EUR | 0.0% |
2017 Q2 | 44.65 Million EUR | 0.0% |
2017 FY | 100.33 Million EUR | 7.48% |
2016 Q2 | 41.9 Million EUR | 0.0% |
2016 FY | 93.35 Million EUR | 15.56% |
2016 Q4 | 51.45 Million EUR | 0.0% |
2015 Q4 | 46.36 Million EUR | 0.0% |
2015 FY | 80.78 Million EUR | 13.64% |
2015 Q2 | 34.42 Million EUR | 0.0% |
2014 FY | 71.09 Million EUR | 22.09% |
2014 Q4 | 39.82 Million EUR | 0.0% |
2014 Q2 | 31.27 Million EUR | 0.0% |
2013 Q4 | 33.5 Million EUR | 0.0% |
2013 Q2 | 24.72 Million EUR | 0.0% |
2013 FY | 58.22 Million EUR | 15.84% |
2012 Q1 | 11.81 Million EUR | 0.0% |
2012 Q3 | 12.56 Million EUR | 0.0% |
2012 Q4 | 12.56 Million EUR | 0.0% |
2012 FY | 50.26 Million EUR | 6.39% |
2012 Q2 | 12.56 Million EUR | 6.39% |
2011 Q2 | 11.81 Million EUR | 0.0% |
2011 Q1 | - EUR | 0.0% |
2011 Q4 | 11.81 Million EUR | 0.0% |
2011 FY | 47.24 Million EUR | 0.0% |
2011 Q3 | 11.81 Million EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2010 Q2 | - EUR | 0.0% |
2010 Q3 | - EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Crossject Société Anonyme | 145 Thousand EUR | -73016.552% |
Safe Orthopaedics SA | 5.86 Million EUR | -1708.889% |
Spineway SA | 10.51 Million EUR | -907.881% |
Sartorius Stedim Biotech S.A. | 2.77 Billion EUR | 96.18% |
EssilorLuxottica Société anonyme | 25.39 Billion EUR | 99.583% |
bonyf N.V. | 309.37 Thousand EUR | -34168.878% |